Related Experiment Video
Updated: Feb 10, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Effect of CXCR4 silencing with shRNA on MAPK signaling in ovarian cancer
Xiuli Wang1, Hongying Wang1, Xia Wei1
1Department of Obstetrics and Gynecology, Liaocheng People's Hospital of Shandong Province, Liaocheng, Shandong 252000, P.R. China.
Abstract:
Our previous study demonstrated that short hairpin RNA (shRNA) targeting of C-X-C chemokine receptor type 4 (CXCR4) significantly inhibited cell proliferation, metastasis and invasion. On the basis of these results, the aim of the present study was to determine the effects of shRNA-CXCR4 silencing on mitogen-activated protein kinase (MAPK) signaling in human SW626 ovarian cancer cells. Following silencing the CXCR4 gene with shRNA, the mRNA expression of apoptosis signal-regulating kinase 1 (ASK1) was determined using the reverse transcription-quantitative polymerase chain reaction, whereas the protein expression of extracellular-signal-regulated kinase (ERK)1/2 and phosphorylated (p)-c-Jun were determined using immunocytochemistry and western blotting. SW626 cells transfected with shRNA-CXCR4 exhibited significantly increased ASK1 mRNA expression (P<0.05), significantly increased p-c-Jun protein expression (P<0.05), and significantly decreased ERK1/2 protein expression (P<0.05). Silencing the CXCR4 gene with shRNA significantly inhibited cell proliferation, promoted cell apoptosis and may be mediated by the MAPK signaling pathway.
Insights
Silencing C-X-C chemokine receptor type 4 (CXCR4) with shRNA inhibits ovarian cancer cell growth. This CXCR4 gene silencing impacts mitogen-activated protein kinase (MAPK) signaling, promoting apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Previous research showed short hairpin RNA (shRNA) targeting of C-X-C chemokine receptor type 4 (CXCR4) inhibits cancer cell proliferation, metastasis, and invasion.
- CXCR4 is implicated in various cancer progression mechanisms.
Purpose of the Study:
- To investigate the effects of shRNA-mediated CXCR4 silencing on mitogen-activated protein kinase (MAPK) signaling pathways in human SW626 ovarian cancer cells.
- To understand the molecular mechanisms underlying CXCR4's role in ovarian cancer.
Main Methods:
- SW626 ovarian cancer cells were transfected with shRNA targeting CXCR4.
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to measure apoptosis signal-regulating kinase 1 (ASK1) mRNA expression.
- Immunocytochemistry and western blotting were employed to assess extracellular-signal-regulated kinase (ERK)1/2 and phosphorylated (p)-c-Jun protein levels.
Main Results:
- shRNA-CXCR4 silencing led to a significant increase in ASK1 mRNA expression (P<0.05).
- A significant increase in p-c-Jun protein expression (P<0.05) and a significant decrease in ERK1/2 protein expression (P<0.05) were observed.
- CXCR4 gene silencing significantly inhibited cell proliferation and promoted cell apoptosis.
Conclusions:
- shRNA-mediated silencing of CXCR4 in SW626 ovarian cancer cells impacts MAPK signaling.
- The observed inhibition of cell proliferation and promotion of apoptosis by CXCR4 silencing may be mediated through the MAPK signaling pathway.
Related Concept Videos
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Ovarian Cycle
Endocrine Signaling
Bacterial Signaling
Yeast Signaling

